JP Morgan Raises ISRG Price Target to $350

JP Morgan has issued a report raising the Price Target on Intuitive Surgical ISRG form $325 to $350 a share. According to the report, "With only modest adjustments to revenue and procedure guidance for the year, we see little to change the investment debate, as we maintain our valuation-based Neutral rating and adjust our Dec 2011 price target to $350." ISRG has a Neutral Rating and closed at $375.90 a share yesterday.